Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 4/2003

01-10-2003 | Original Article

Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles

Authors: Jörg B. Engel, Ricardo E. Felberbaum, Klaus Junge, Thomas Reissmann, Klaus Diedrich

Published in: Archives of Gynecology and Obstetrics | Issue 4/2003

Login to get access

Abstract

Materials and methods.

This retrospective study was carried out in order to assess the value of inhibin B as a predictive factor for the assisted reproduction-outcome. Inhibin B on the day of HCG-administration (ovulation induction) was measured in 15 pregnant and 16 non-pregnant patients (defined as positive serum-HCG) and compared by single and multiple logistic regression analysis with classical predictive factors such as estrogen and oocyte number. Both groups were similar with respect to age and cause of infertility.

Results.

While estrogen, FSH and LH at the HCG-day did not differ, inhibin B, the number of cumulus oocyte complexes and metaphase II -oocytes were statistically significantly different. In a single variable logistic model inhibin B, cumulus oocyte complexes and metaphase II oocytes showed significant correlation with pregnancy. When reassessed in a multiple variable logistic model only inhibin B maintained a considerable influence. Further inspection revealed, that the predictive inhibin B value at HCG-day <1200 pg/ml for failure of ART (assisted reproduction techniques) was 91%. Inhibin >1200 pg/ml showed 70% predictivity for pregnancy.

Conclusion.

In comparison to classical parameters inhibin B at HCG-day seems to be the better prognostic factor for the outcome of ART. Inhibin B <1200 pg/ml seems to be highly predictive for failure of ART.
Literature
1.
go back to reference Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Diedrich K, Devroey P (2000) Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinizing-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15:526–531CrossRefPubMed Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Diedrich K, Devroey P (2000) Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinizing-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15:526–531CrossRefPubMed
2.
go back to reference Creus M, Penarrubia J, Fábregues F (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 11:2341–2346CrossRef Creus M, Penarrubia J, Fábregues F (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 11:2341–2346CrossRef
3.
go back to reference Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, Krebs D (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9:788–791PubMed Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, Krebs D (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9:788–791PubMed
4.
go back to reference Eldar-Geva T, Robertson MD, Cahir N, Groome N, Gabbe MP, MacLachlan V, Healy DL (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Endocrinol Metab 85:607–613 Eldar-Geva T, Robertson MD, Cahir N, Groome N, Gabbe MP, MacLachlan V, Healy DL (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Endocrinol Metab 85:607–613
5.
go back to reference Engel JB, Felberbaum R, Reissmann T, Kose R, Diedrich K (2001) Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication. Reprod Biomed 3:104–108CrossRef Engel JB, Felberbaum R, Reissmann T, Kose R, Diedrich K (2001) Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication. Reprod Biomed 3:104–108CrossRef
6.
go back to reference Groome NP, Illingworth PJ, Cooke I, Ganesan TS, Baird DT, McNeilly AS (1994) Detection of dimeric inhibin throughout the human menstrual cycle by 2-site enzyme immunoassay. Clin Endocrinol 6:717–723CrossRef Groome NP, Illingworth PJ, Cooke I, Ganesan TS, Baird DT, McNeilly AS (1994) Detection of dimeric inhibin throughout the human menstrual cycle by 2-site enzyme immunoassay. Clin Endocrinol 6:717–723CrossRef
7.
go back to reference Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Marther JP, McNeilly AS (1996) Measurement of dimeric inhibin-B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401–1405PubMed Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Marther JP, McNeilly AS (1996) Measurement of dimeric inhibin-B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401–1405PubMed
8.
go back to reference Hall JE, Welt CK, Cramer DW (1999) Inhibin A and B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14:409–415CrossRefPubMed Hall JE, Welt CK, Cramer DW (1999) Inhibin A and B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14:409–415CrossRefPubMed
9.
go back to reference Lockwood GM, Muttukrishna S, Groome NP, Ledger WL (1996) Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilisation-embryo transfer. Clin Endocrinol 45:741–748CrossRef Lockwood GM, Muttukrishna S, Groome NP, Ledger WL (1996) Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilisation-embryo transfer. Clin Endocrinol 45:741–748CrossRef
10.
go back to reference Lockwood GM, Muttukrishna S, Ledger WL (1998) Inhibins and activins in human ovulation conception and pregnancy. Hum Reprod Update 4:284–295CrossRefPubMed Lockwood GM, Muttukrishna S, Ledger WL (1998) Inhibins and activins in human ovulation conception and pregnancy. Hum Reprod Update 4:284–295CrossRefPubMed
11.
go back to reference Ludwig M, Felberbaum RE, Diedrich K, Hamm W, Riethmüller-Winzen H, Ulrich H (2000) Cetrorelix (Cetrotide®) im Mehrfachgabe. Protokoll zur ovariellen Stimulation bei der IVF. Reproduktionsmedizin 16:390–399CrossRef Ludwig M, Felberbaum RE, Diedrich K, Hamm W, Riethmüller-Winzen H, Ulrich H (2000) Cetrorelix (Cetrotide®) im Mehrfachgabe. Protokoll zur ovariellen Stimulation bei der IVF. Reproduktionsmedizin 16:390–399CrossRef
12.
go back to reference Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG (1994) Serum concentration of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 9:1634–1642PubMed Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG (1994) Serum concentration of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 9:1634–1642PubMed
13.
go back to reference Penarrubia J, Balasch J, Fábregues F, Carmna F, Casamitjana R, Moreno V, Calafell J, Vanrell JA (2000) Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist gonadotrophin treatment. Hum Reprod 7:1499–1502CrossRef Penarrubia J, Balasch J, Fábregues F, Carmna F, Casamitjana R, Moreno V, Calafell J, Vanrell JA (2000) Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist gonadotrophin treatment. Hum Reprod 7:1499–1502CrossRef
14.
go back to reference Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA (1997) Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril 67:11–15CrossRef Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA (1997) Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril 67:11–15CrossRef
Metadata
Title
Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles
Authors
Jörg B. Engel
Ricardo E. Felberbaum
Klaus Junge
Thomas Reissmann
Klaus Diedrich
Publication date
01-10-2003
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 4/2003
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0442-0

Other articles of this Issue 4/2003

Archives of Gynecology and Obstetrics 4/2003 Go to the issue